300181 佐力药业
已收盘 11-12 15:00:00
资讯
新帖
简况
佐力药业(300181)11月10日主力资金净卖出40.32万元
证券之星 · 11-11 09:23
佐力药业(300181)11月10日主力资金净卖出40.32万元
佐力药业(300181)披露向不特定对象发行可转换公司债券上市公告书,11月09日股价下跌0.64%
证券之星 · 11-09 22:40
佐力药业(300181)披露向不特定对象发行可转换公司债券上市公告书,11月09日股价下跌0.64%
股市必读:佐力药业新发布《关于获得《药品补充申请批准通知书》的公告》
证券之星 · 11-05
股市必读:佐力药业新发布《关于获得《药品补充申请批准通知书》的公告》
佐力药业(300181)披露获得《药品补充申请批准通知书》,11月03日股价上涨1.3%
证券之星 · 11-03
佐力药业(300181)披露获得《药品补充申请批准通知书》,11月03日股价上涨1.3%
股市必读:佐力药业新发布《向不特定对象发行可转换公司债券网上发行中签率及优先配售结果公告》
证券之星 · 11-02
股市必读:佐力药业新发布《向不特定对象发行可转换公司债券网上发行中签率及优先配售结果公告》
佐力药业:2026年既定目标的完成存在较大的难度
证券之星 · 10-30
佐力药业:2026年既定目标的完成存在较大的难度
佐力药业(300181)10月29日主力资金净卖出2323.59万元
证券之星 · 10-30
佐力药业(300181)10月29日主力资金净卖出2323.59万元
10月29日佐力药业跌6.61%,浙商汇金量化精选混合A基金重仓该股
证券之星 · 10-29
10月29日佐力药业跌6.61%,浙商汇金量化精选混合A基金重仓该股
佐力药业(300181.SZ)发布前三季度业绩,归母净利润4.95亿元,同比下降3.00%
智通财经 · 10-27
佐力药业(300181.SZ)发布前三季度业绩,归母净利润4.95亿元,同比下降3.00%
【持股配债】佐力药业发行“13.71亿”可转债,10月28日配债分析!
自由可转债 · 10-26
【持股配债】佐力药业发行“13.71亿”可转债,10月28日配债分析!
股市必读:佐力药业(300181)10月22日董秘有最新回复
证券之星 · 10-23
股市必读:佐力药业(300181)10月22日董秘有最新回复
佐力药业:公司及子公司与华东医药的购销属于商业化业务往来
证券之星 · 10-22
佐力药业:公司及子公司与华东医药的购销属于商业化业务往来
股市必读:佐力药业(300181)10月19日董秘有最新回复
证券之星 · 10-20
股市必读:佐力药业(300181)10月19日董秘有最新回复
佐力药业:浙江佐力医药有限公司系公司全资二级子公司
证券之星 · 10-19
佐力药业:浙江佐力医药有限公司系公司全资二级子公司
佐力药业(300181)披露向不特定对象发行可转换公司债券获证监会注册批复,10月12日股价上涨0.45%
证券之星 · 10-12
佐力药业(300181)披露向不特定对象发行可转换公司债券获证监会注册批复,10月12日股价上涨0.45%
深交所创业板再融资审核动态周报(截止10月10日)
览富财经网 · 10-12
深交所创业板再融资审核动态周报(截止10月10日)
佐力药业:发行可转换公司债券获证监会同意注册批复
每日经济新闻 · 10-11
佐力药业:发行可转换公司债券获证监会同意注册批复
股市必读:佐力药业(300181)9月24日披露最新机构调研信息
证券之星 · 09-28
股市必读:佐力药业(300181)9月24日披露最新机构调研信息
佐力药业:9月23日组织现场参观活动,开源证券参与
证券之星 · 09-24
佐力药业:9月23日组织现场参观活动,开源证券参与
股市必读:佐力药业新发布《国金证券股份有限公司关于浙江佐力药业股份有限公司向不特定对象发行可转换公司债券之发行保荐书(2026年半年度财务数据更新版)》
证券之星 · 09-11
股市必读:佐力药业新发布《国金证券股份有限公司关于浙江佐力药业股份有限公司向不特定对象发行可转换公司债券之发行保荐书(2026年半年度财务数据更新版)》
加载更多
公司概况
公司名称:
浙江佐力药业股份有限公司
所属行业:
医药制造业
上市日期:
2011-02-22
主营业务:
浙江佐力药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是乌灵胶囊、灵泽片、灵莲花颗粒、百令片、百令胶囊、聚卡波非钙片/颗粒。公司荣获“全国文明单位”“国家级绿色工厂”“浙江省知名商号”“浙江省重合同、守信用AAA级企业”“浙江省信用管理示范企业”“浙江省中医药文化宣传教育基地”等称号和荣誉。
发行价格:
23.50
{"stockData":{"symbol":"300181","market":"SZ","secType":"STK","nameCN":"佐力药业","latestPrice":12.23,"timestamp":1794467016000,"preClose":12.33,"halted":0,"volume":6445445,"delay":0,"changeRate":-0.0081,"floatShares":602000000,"shares":701000000,"eps":0.8792,"marketStatus":"已收盘","change":-0.1,"latestTime":"11-12 15:00:00","open":12.32,"high":12.39,"low":12.17,"amount":79049300,"amplitude":0.0178,"askPrice":12.24,"askSize":6,"bidPrice":12.23,"bidSize":117,"shortable":0,"etf":0,"ttmEps":0.8792,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794533400000},"marketStatusCode":5,"adr":0,"adjPreClose":12.33,"symbolType":"stock","openAndCloseTimeList":[[1794447000000,1794454200000],[1794459600000,1794466800000]],"highLimit":13.56,"lowLimit":11.1,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":701387335,"isCdr":false,"pbRate":2.72,"roa":"--","peRate":13.910373,"roe":"14.93%","epsLYR":0.92,"committee":-0.125,"marketValue":8578000000,"turnoverRate":0.0107,"status":1,"floatMarketCap":7369000000},"requestUrl":"/m/hq/s/300181/","defaultTab":"news","newsList":[{"id":"2682430323","title":"佐力药业(300181)11月10日主力资金净卖出40.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682430323","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682430323?lang=zh_cn&edition=full","pubTime":"2026-11-11 09:23","pubTimestamp":1794360233,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月10日收盘,佐力药业报收于12.36元,下跌0.64%,换手率1.04%,成交量6.3万手,成交额7816.91万元。近5日资金流向一览见下表:佐力药业融资融券信息显示,融资方面,当日融资买入1584.03万元,融资偿还717.91万元,融资净买入866.12万元。佐力药业主营业务:药品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100014613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0239","300181","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682138127","title":"佐力药业(300181)披露向不特定对象发行可转换公司债券上市公告书,11月09日股价下跌0.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682138127","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682138127?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:40","pubTimestamp":1794235258,"startTime":"0","endTime":"0","summary":"截至2026年11月9日收盘,佐力药业报收于12.44元,较前一交易日下跌0.64%,最新总市值为87.25亿元。该股当日开盘12.57元,最高12.6元,最低12.44元,成交额达5849.14万元,换手率为0.78%。公司于2026年11月9日披露《浙江佐力药业股份有限公司向不特定对象发行可转换公司债券上市公告书》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900024459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","300181","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681066279","title":"股市必读:佐力药业新发布《关于获得《药品补充申请批准通知书》的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2681066279","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681066279?lang=zh_cn&edition=full","pubTime":"2026-11-05 01:23","pubTimestamp":1793813013,"startTime":"0","endTime":"0","summary":"公司公告汇总关于获得《药品补充申请批准通知书》的公告浙江佐力药业股份有限公司收到国家药监局签发的《药品补充申请批准通知书》,批准多种微量元素注射液的上市许可持有人由合肥市未来药物开发有限公司变更为本公司。药品批准文号不变,生产场地、处方、工艺及质量标准均未发生变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500002808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300181","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680720350","title":"佐力药业(300181)披露获得《药品补充申请批准通知书》,11月03日股价上涨1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680720350","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680720350?lang=zh_cn&edition=full","pubTime":"2026-11-03 22:39","pubTimestamp":1793716750,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘,佐力药业报收于12.43元,较前一交易日上涨1.3%,最新总市值为87.18亿元。该股当日开盘12.26元,最高12.48元,最低12.2元,成交额达1.05亿元,换手率为1.41%。近日,浙江佐力药业股份有限公司收到国家药监局签发的《药品补充申请批准通知书》,批准多种微量元素注射液的上市许可持有人由合肥市未来药物开发有限公司变更为本公司。药品批准文号不变,生产场地、处方、工艺及质量标准均未发生变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300045775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0042","300181","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680178871","title":"股市必读:佐力药业新发布《向不特定对象发行可转换公司债券网上发行中签率及优先配售结果公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680178871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680178871?lang=zh_cn&edition=full","pubTime":"2026-11-02 06:59","pubTimestamp":1793573949,"startTime":"0","endTime":"0","summary":"公司公告汇总:佐力药业向不特定对象发行可转债中签结果公布,中签号码共364,839个,每个可认购10张;缴款截止日为2026年11月2日日终,连续12个月内累计3次中签未足额缴款将被限制申购6个月。公司公告汇总向不特定对象发行可转换公司债券中签号码公告浙江佐力药业股份有限公司向不特定对象发行可转换公司债券,已完成网上发行中签摇号,中签结果已由公证机构公证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200001849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0239","300181","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679984212","title":"佐力药业:2026年既定目标的完成存在较大的难度","url":"https://stock-news.laohu8.com/highlight/detail?id=2679984212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679984212?lang=zh_cn&edition=full","pubTime":"2026-10-30 16:36","pubTimestamp":1793349376,"startTime":"0","endTime":"0","summary":"证券之星消息,佐力药业(300181)10月30日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司2026年的股权激励有信息完成吗佐力药业回复:您好!公司于 2024 年基于当时市场环境制定了三年业绩考核目标,2025 年公司已顺利完成第一年的考核目标,但受当前宏观市场环境和政策变化影响,2026 年既定目标的完成存在较大的难度。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000040588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","300181","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679251634","title":"佐力药业(300181)10月29日主力资金净卖出2323.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679251634","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679251634?lang=zh_cn&edition=full","pubTime":"2026-10-30 09:22","pubTimestamp":1793323344,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月29日收盘,佐力药业报收于12.0元,下跌6.61%,换手率4.08%,成交量24.56万手,成交额2.97亿元。近5日资金流向一览见下表:佐力药业融资融券信息显示,融资方面,当日融资买入9161.6万元,融资偿还4609.53万元,融资净买入4552.06万元。佐力药业主营业务:药品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000017044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","300181","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679475487","title":"10月29日佐力药业跌6.61%,浙商汇金量化精选混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679475487","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679475487?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:59","pubTimestamp":1793264368,"startTime":"0","endTime":"0","summary":"证券之星消息,10月29日佐力药业跌6.61%创60日新低,收盘报12.0元,换手率4.08%,成交量24.56万手,成交额2.97亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为浙商证券资管的浙商汇金量化精选混合A。浙商汇金量化精选混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900041054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300181","BK0077","BK0042","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678121240","title":"佐力药业(300181.SZ)发布前三季度业绩,归母净利润4.95亿元,同比下降3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678121240","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678121240?lang=zh_cn&edition=full","pubTime":"2026-10-27 16:46","pubTimestamp":1793090762,"startTime":"0","endTime":"0","summary":"智通财经APP讯,佐力药业(300181.SZ)发布2026年三季度报告,前三季度,公司实现营业收入25.1亿元,同比增长10.10%。归属于上市公司股东的净利润4.95亿元,同比下降3.00%。归属于上市公司股东的扣除非经常性损益的净利润4.96亿元,同比下降2.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513297.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678019499","title":"【持股配债】佐力药业发行“13.71亿”可转债,10月28日配债分析!","url":"https://stock-news.laohu8.com/highlight/detail?id=2678019499","media":"自由可转债","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678019499?lang=zh_cn&edition=full","pubTime":"2026-10-26 21:53","pubTimestamp":1793022780,"startTime":"0","endTime":"0","summary":"公司2026年半年报显示的营业总收入为17.64亿元,同比增长10.30%。扣非归母净利润为3.73亿元,同比增长0.53%。转债发行规模为13.71亿,转股价值为100.30元。若第1大股东配债,最小流通规模约11.17亿。持股配债:10月28日当天收盘后,持有500股“佐力药业”的股票。若可用资金不足,持有的股票开盘后可以直接卖出,卖出后的资金可以直接用于配债缴款。配售简称:佐力配债配售代码:380181新债上市行情:次新债价格回落,重点留意新债上市首日尾盘价格变动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-26/doc-iniwqpfm5203850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0077","BK0042","FCEF","BK0239","SABA","300181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677998506","title":"股市必读:佐力药业(300181)10月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2677998506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677998506?lang=zh_cn&edition=full","pubTime":"2026-10-23 01:43","pubTimestamp":1792690989,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘,佐力药业报收于12.86元,下跌2.21%,换手率1.26%,成交量7.59万手,成交额9865.12万元。公司及子公司与华东医药的购销属于商业化业务往来,基于市场化条件协商定价,不存在利益交换或利益输送。交易信息汇总资金流向10月22日主力资金净流出1541.78万元,占总成交额15.63%;游资资金净流入48.15万元,占总成交额0.49%;散户资金净流入1493.63万元,占总成交额15.14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300001991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300181","BK0077","BK0239","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677995340","title":"佐力药业:公司及子公司与华东医药的购销属于商业化业务往来","url":"https://stock-news.laohu8.com/highlight/detail?id=2677995340","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677995340?lang=zh_cn&edition=full","pubTime":"2026-10-22 17:12","pubTimestamp":1792660329,"startTime":"0","endTime":"0","summary":"公司及子公司与华东医药的购销属于商业化业务往来,基于市场化条件协商定价,不存在利益交换或利益输送。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200029340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300181","BK0209","BK0187","BK0183","LU1969619763.USD","BK0077","BK0188","LU2328871848.SGD","000963","BK0196","BK0175","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676638383","title":"股市必读:佐力药业(300181)10月19日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2676638383","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676638383?lang=zh_cn&edition=full","pubTime":"2026-10-20 01:19","pubTimestamp":1792430348,"startTime":"0","endTime":"0","summary":"截至2026年10月19日收盘,佐力药业报收于13.27元,上涨1.14%,换手率1.65%,成交量9.92万手,成交额1.32亿元。董秘最新回复投资者: 请问贵公司206年三季报业绩怎么样?公司2026年三季度报告预约披露日为2026年10月28日,具体经营及业绩情况届时请关注公司在法定披露媒体披露的信息。根据公司披露的2026年半年度报告,佐力医药公司商业营业收入较上年同期数增长了49.97%。当日关注点交易信息汇总:10月19日主力资金净流入557.97万元,占总成交额4.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000001765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0042","300181","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676017509","title":"佐力药业:浙江佐力医药有限公司系公司全资二级子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2676017509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676017509?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:51","pubTimestamp":1792399870,"startTime":"0","endTime":"0","summary":"证券之星消息,佐力药业(300181)10月19日在投资者关系平台上答复投资者关心的问题。投资者提问:请问子公司佐力医药在上市公司中的定位,他的业务盈利能力如何?是否存在亏损?佐力药业回复:您好!浙江佐力医药有限公司系公司全资二级子公司,重点经营特色的医药流通业务,作为对主业的协同与补充。根据公司披露的2026年半年度报告,佐力医药公司商业营业收入较上年同期数增长了49.97%。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900021131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1161","300181","BK0077","09939","BK0239","BK1574","BK1515","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674876964","title":"佐力药业(300181)披露向不特定对象发行可转换公司债券获证监会注册批复,10月12日股价上涨0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674876964","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674876964?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:52","pubTimestamp":1791798740,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘,佐力药业报收于13.31元,较前一交易日上涨0.45%,最新总市值为93.35亿元。近日,浙江佐力药业股份有限公司收到中国证券监督管理委员会出具的《关于同意浙江佐力药业股份有限公司向不特定对象发行可转换公司债券注册的批复》。中国证监会同意公司向不特定对象发行可转换公司债券的注册申请,批复自同意注册之日起12个月内有效。公司董事会将根据相关要求及股东会授权办理后续事宜,并履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200024292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300181","BK0239","BK0077","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674873406","title":"深交所创业板再融资审核动态周报(截止10月10日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674873406","media":"览富财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674873406?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:04","pubTimestamp":1791795840,"startTime":"0","endTime":"0","summary":"公司2月27日获深交所受理,8月21日经上市审核委员会2026年第52次会议审议通过,保荐机构为国金证券股份有限公司。公司5月15日获深交所受理,9月9日审核通过,9月21日提交注册,保荐机构为国联民生证券承销保荐有限公司。公司于9月23日收到深交所上市审核中心出具的审核中心意见告知函,9月24日公告审核通过,9月30日提交注册。公司6月1日获深交所受理,7月9日已完成首轮问询回复,保荐机构为国泰海通证券股份有限公司。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-12/doc-iniuyhwz5260372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0064","301279","BK0141","300181","300756","BK0091","300852","300814","BK0185","BK0214","BK0077","BK0254","BK0197","300656","301631","BK0170","301251","BK0042","300323","BK0102","BK0239","BK0259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674158812","title":"佐力药业:发行可转换公司债券获证监会同意注册批复","url":"https://stock-news.laohu8.com/highlight/detail?id=2674158812","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674158812?lang=zh_cn&edition=full","pubTime":"2026-10-11 16:48","pubTimestamp":1791708480,"startTime":"0","endTime":"0","summary":"每经AI快讯,10月11日,佐力药业公告,公司拟向不特定对象发行可转换公司债券,近日收到中国证监会同意注册批复,批复自同意注册之日起12个月内有效。公司将按相关要求及股东会授权办理本次发行相关事宜。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-11/doc-iniuvxsm8846901.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-11/doc-iniuvxsm8846901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0042","BK0239","300181","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409333","title":"股市必读:佐力药业(300181)9月24日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409333","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409333?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:12","pubTimestamp":1790529132,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘,佐力药业报收于12.95元,下跌1.52%,换手率1.28%,成交量7.69万手,成交额1.0亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","300181","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669305496","title":"佐力药业:9月23日组织现场参观活动,开源证券参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2669305496","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669305496?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:03","pubTimestamp":1790258636,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年9月24日佐力药业发布公告称公司于2026年9月23日组织现场参观活动,开源证券巢舒然参与。公司中药配方颗粒 2026 年上半年实现营收 9700 多万,同比增长 31%。公司向不特定对象发行可转换公司债券申请已经深交所上市委审核通过,尚需中国证监会同意注册。佐力药业主营业务:药品的研发、生产和销售。该股最近90天内共有3家机构给出评级,买入评级3家。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400040633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0239","BK0077","300181","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666590395","title":"股市必读:佐力药业新发布《国金证券股份有限公司关于浙江佐力药业股份有限公司向不特定对象发行可转换公司债券之发行保荐书(2026年半年度财务数据更新版)》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666590395","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666590395?lang=zh_cn&edition=full","pubTime":"2026-09-11 01:41","pubTimestamp":1789062069,"startTime":"0","endTime":"0","summary":"公司公告汇总:佐力药业向不特定对象发行可转债申请已于2026年8月21日获深交所上市审核委员会审议通过,募集说明书等文件已基于2026年半年报完成财务数据更新。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0012","BK0188","600109","BK0201","BK0042","BK0028","300181","BK0239","BK0276","BK0077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794491175999,"stockEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0736},{"period":"3month","weight":-0.1505},{"period":"6month","weight":-0.1241},{"period":"1year","weight":-0.2688},{"period":"ytd","weight":-0.1973}],"compareEarnings":[{"period":"1week","weight":-0.0015},{"period":"1month","weight":-0.0307},{"period":"3month","weight":-0.0627},{"period":"6month","weight":-0.11},{"period":"1year","weight":-0.0805},{"period":"ytd","weight":-0.0726}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江佐力药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"49164人(较上一季度增加11.24%)","perCapita":"12254股","listingDate":"2011-02-22","address":"浙江省湖州市德清县阜溪街道志远北路388号","registeredCapital":"70138万元","survey":" 浙江佐力药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是乌灵胶囊、灵泽片、灵莲花颗粒、百令片、百令胶囊、聚卡波非钙片/颗粒。公司荣获“全国文明单位”“国家级绿色工厂”“浙江省知名商号”“浙江省重合同、守信用AAA级企业”“浙江省信用管理示范企业”“浙江省中医药文化宣传教育基地”等称号和荣誉。","listedPrice":23.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"佐力药业(300181)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供佐力药业(300181)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"佐力药业,300181,佐力药业股票,佐力药业股票老虎,佐力药业股票老虎国际,佐力药业行情,佐力药业股票行情,佐力药业股价,佐力药业股市,佐力药业股票价格,佐力药业股票交易,佐力药业股票购买,佐力药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"佐力药业(300181)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供佐力药业(300181)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}